A US District Court in Delaware approved Lunai Bioworks' request for expedited discovery to identify anonymous "naked" short sellers who manipulated its stock on Nasdaq in late 2025 and early 2026. Lunai alleges these sellers illegally shorted its shares without borrowing them, causing market harm. The company, an AI-driven precision medicine firm, seeks damages and plans to amend its complaint to include civil RICO claims. Discovery will start with broker-dealers to uncover the identities of the wrongdoers and halt ongoing manipulative trading.
President Donald Trump stated that negotiations with Iran over its nuclear program are proceeding in an orderly and constructive manner. He emphasized the need for patience and warned against rushing the deal, maintaining the U.S. naval blockade on I...
Elon Musk is advancing his AI ambitions through xAI, backed by Tesla's $2 billion investment, positioning Tesla as the public proxy for Musk's AI efforts. This move challenges OpenAI, primarily partnered with Microsoft, which reported strong AI-drive...
Bitcoin's recent price action resembles a bearish pattern from 2022, where a second, deeper drop followed an initial decline. The cryptocurrency has fallen below its 200-day moving average and formed a bear flag, signaling potential further downside ...
SpaceX, led by Elon Musk, is preparing for an IPO with a valuation target of $1.75 trillion. Financial data firms S&P Global and MSCI will determine which sector SpaceX fits into, considering its diverse business areas including space launches, satel...
Ethereum's leveraged bullish positions are increasing despite weakening spot market demand and resistance near $2,150-$2,200. Institutional outflows and rising macroeconomic pressures, including higher Treasury yields and dollar strength, are limitin...
